KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardant Health (GH) Income from Non-Controlling Interests (2018 - 2021)

Guardant Health's Income from Non-Controlling Interests history spans 4 years, with the latest figure at $18.6 million for Q4 2021.

  • For Q4 2021, Income from Non-Controlling Interests rose 2557.14% year-over-year to $18.6 million; the TTM value through Sep 2022 reached $18.6 million, up 520.0%, while the annual FY2021 figure was $20.9 million, 178.67% up from the prior year.
  • Income from Non-Controlling Interests for Q4 2021 was $18.6 million at Guardant Health, up from $2.3 million in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $18.6 million in Q4 2021 and bottomed at -$4.1 million in Q1 2020.
  • The 4-year median for Income from Non-Controlling Interests is $1.6 million (2018), against an average of $3.1 million.
  • The largest annual shift saw Income from Non-Controlling Interests tumbled 187.23% in 2020 before it soared 2557.14% in 2021.
  • A 4-year view of Income from Non-Controlling Interests shows it stood at -$150000.0 in 2018, then skyrocketed by 2166.67% to $3.1 million in 2019, then tumbled by 77.42% to $700000.0 in 2020, then skyrocketed by 2557.14% to $18.6 million in 2021.
  • Per Business Quant, the three most recent readings for GH's Income from Non-Controlling Interests are $18.6 million (Q4 2021), $2.3 million (Q1 2021), and $700000.0 (Q4 2020).